AxelssonJ., HeimbürgerO., LindholmB., StenvinkelP.Adipose tissue and its relation to inflammation: The role of adipokines.J Ren Nutr2005; 15: 131–6.
2.
AxelssonJ., QureshiA.R., SulimanM.E., HondaH., Pecoits-FilhoR., HeimbürgerO.Truncal fat mass as a contributor to inflammation in end-stage renal disease.Am J Clin Nutr2004; 80: 1222–9.
3.
StenvinkelP., ChungS-H, HeimbürgerO., LindholmB.Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients.Perit Dial Int2001; 21(Suppl 3): S157–62.
4.
Mohamed-AliV., GoodrickS., RaweshA., KatzD.R., MilesJ.M., YudkinJ.S.Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-α, in vivo.J Clin Endocrinol Metab1997; 82: 4196–200.
5.
PajvaniU.B., HawkinsM., CombsT.P., RajalaM.W., DoebberT., BergerJ.P.Complex distribution, not absolute amount of adiponectin, correlates with thiazolidedionemediated improvement in insulin sensitivity.J Biol Chem2004; 279: 12152–62.
6.
HottaK., FunahashiT., AritaY., TakahashiM., MatsudaM., OkamatoY.Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.Arterioscler Thromb Vasc Biol2000; 20: 1595–9.
7.
RajalaM.W., SchererP.E.Minireview: The adipocyte — at the crossroads of energy homeostasis, inflammation, and atherosclerosis.Endocrinology2003; 144: 3765–73.
8.
BeckerB., KronenbergF., KielsteinJ.T., HallerH., MorathC., RitzE.Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study.J Am Soc Nephrol2005; 16: 1091–8.
9.
ZoccaliF., MallamaciF., TripepiG., CutrupiS., ParlongoS., MalatinoL.Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.J Am Soc Nephrol2002; 13: 134–41.
10.
OuchiN., KiharaS., AritaY., OkamatoY., MaedaK., KuriyamaH.Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signalling through a cAMP-dependent pathway.Circulation2000; 102: 1296–301.
11.
SprangerJ., KrokeA., MohligM., BergmannM.M., RistowM., BoeingH.Adiponectin and protection against type-2 diabetes mellitus.Lancet2003; 361: 226–8.
12.
Guebre-EgziabherF., BernhardJ., FunahashiT., Hadj-AissaA., FouqueD.Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.Nephrol Dial Transplant2005; 20: 129–34.
13.
StenvinkelP., MarchlewskaA., Pecoits-FilhoR., HeimbürgerO., ZhangZ., HoffC.Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin.Kidney Int2003; 65: 274–81.
14.
DíezJ.J., IglesiasP., Fernández-ReyesM.J., AguileraA., BajoM.A., Alvarez-FidalgoP.Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.Clin Endocrinol (Oxf)2005; 62: 242–9.
ShojiT., ShinoharaK., HatsudaS., KimotoE., FukomotoM., EmotoM.Altered relationship between body fat and plasma adiponectin in end-stage renal disease.Metabolism2005; 54: 330–4.
17.
HeimburgerO., LonnqvistF., DanielssonA., NordenstromJ., StenvinkelP.Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure.J Am Soc Nephrol1997; 8: 1423–30.
18.
StenvinkelP., LindholmB., LönnqvistF., KatzarskiK., HeimbürgerO.Increases in serum leptin during peritoneal dialysis are associated with inflammation and a decrease in lean body mass.J Am Soc Nephrol2000; 11: 1303–9.
19.
PatelS.D., RajalaM.W., RosettiL., SchererP.E., ShapiroL.Disulfide-dependent multimeric assembly of resistin family hormones.Science2004; 304: 1154–8.
PatelL., BuckelsA.C., KinghornI.J., MurdockP.R., HolbrookJ.D., PlumptonC.Resistin is expressed in human macrophages and directly regulated by PPARg activators.Biochem Biophys Res Commun2003; 300: 472–6.
22.
KielsteinJ.T., BeckerB., GrafS., BrabantG., HallerH., FliserD.Increased resistin blood levels are not associated with insulin resistance in patients with renal disease.Am J Kidney Dis2003; 42: 62–6.
23.
ReillyM.P., LehrkeM., WolfeM.L., RohatgiA., LazarM.A., RaderD.J.Resistin is an inflammatory marker of atherosclerosis in humans.Circulation2005; 111: 932–9.
24.
HugC., LodishH.F.Visfatin: A new adipokine.Science2005; 307: 366–7.
